-
Incorporating Real-World Data and Mathematical Modeling to Estimate the Undiagnosed Chronic Hepatitis B Population
Sep 18, 2025, 18:38 PM -
Prediction of Rare Disease Medication Transition Patterns Based on an Interpretable Machine Learning Model
Sep 18, 2025, 18:38 PM -
Acceptance of Real-World Evidence in HTA in Japan: Is the Potential Being Realized?
Sep 18, 2025, 18:38 PM -
Estimating Healthcare Costs Associated With Ischemic Heart Disease and Stroke Using Several Different Statistical Models
Sep 18, 2025, 18:38 PM -
Integrating Real World Evidence in Economic Evaluation of Herpes Zoster Vaccination Among Kidney Transplant Patients in Thailand
Sep 18, 2025, 18:38 PM -
Predicting Survival in Multiple Myeloma Patients With Diabetes Using Machine Learning: A 20-Year Cohort Study
Sep 18, 2025, 18:38 PM -
Adoption of Recommendations in the Reference Framework for Children's Health in Primary Care: A Survey of Practices, Barriers, and Enablers Among Primary Care Practitioners in Hong Kong
Sep 18, 2025, 18:38 PM -
Healthcare Utilization Patterns in Early-Stage Breast Cancer Taiwanese Patients: A Real World Evidence-Based Subtype-Specific Study
Sep 18, 2025, 18:38 PM -
Real-World Utilization, Persistence, and Effectiveness of Biologic Therapies in Patients With Severe Asthma: A Multicenter Retrospective Cohort Study in Taiwan
Sep 18, 2025, 18:38 PM -
Consensus-Based Guidance for Bone Health Optimization in Spine Surgery
Sep 18, 2025, 18:38 PM -
Evaluating the Representativeness of a Real-World Oncology Database Developed by the J-CONNECT Consortium: Comparison With Japan's National Cancer Registry
Sep 18, 2025, 18:38 PM -
Trends in the Incorporation of Clinical Outcome Assessments in Asthma Drug Development in Japan: A Five-Year Review (2020-2024)
Sep 18, 2025, 18:38 PM -
Prescription Trends for ADHD Medications in Japan, 2018-2023
Sep 18, 2025, 18:38 PM -
Unpacking the Modular Payment of the Lead Maternity Carer Service in New Zealand: Developing Initial Program Theory in Realist Economic Evaluation
Sep 18, 2025, 18:38 PM -
Unlocking the Strategic Potential of Real-World Evidence in the Asia – Pacific Pharmaceutical Market: Executive Insights and Commercial Implications
Sep 18, 2025, 18:38 PM -
Using Scaling Factor Model to Estimate the Value Set of Psoriasis Bolt-On EQ-5D-5L Health States
Sep 18, 2025, 18:38 PM -
Cost-Effectiveness of Dostarlimab Plus Chemotherapy for Primary Advanced or Recurrent Endometrial Cancer From Taiwan’s National Health Insurance Perspective
Sep 18, 2025, 18:38 PM -
Economic Implications of Generic Pomalidomide Adoption in the Management of Relapsed/Refractory Multiple Myeloma: A Budget Impact Analysis at the Jalisco Institute of Cancerology
Sep 18, 2025, 18:38 PM -
Factors Influencing Drug Guidance Outcomes in Singapore: A Review of 2023-2024 Appraisals
Sep 18, 2025, 18:38 PM -
Pharmaceutical Approaches to Enhancing RWE Data Collected in Non-Interventional Studies
Sep 18, 2025, 18:38 PM
